Recent Quotes (30 days)

You have no recent quotes
chg | %

Mitsubishi Tanabe Pharma Corp  

(Public, TYO:4508)   Watch this stock  
Find more results for 4508
2,583.00
+9.00 (0.35%)
Jun 23 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 2,576.00 - 2,602.00
52 week 1,729.00 - 2,609.00
Open 2,589.00
Vol. 634,500.00
Mkt cap 1.45T
P/E 20.33
Div/yield 28.00/2.01
EPS 127.03
Shares 560.99M
Beta     -
Inst. own     -
Jul 31, 2017
Q1 2018 Mitsubishi Tanabe Pharma Corp Earnings Release Add to calendar
Jun 22, 2017
Mitsubishi Tanabe Pharma Corp Annual Shareholders Meeting (Estimated)
Jun 21, 2017
Mitsubishi Tanabe Pharma Corp Annual Shareholders Meeting
May 11, 2017
Full Year 2017 Mitsubishi Tanabe Pharma Corp Earnings Presentation (Japanese) - Webcast
May 11, 2017
Full Year 2017 Mitsubishi Tanabe Pharma Corp Earnings Presentation - Webcast
May 10, 2017
Full Year 2017 Mitsubishi Tanabe Pharma Corp Earnings Release
  

Key stats and ratios

Q1 (Mar '17) 2017
Net profit margin 10.42% 16.26%
Operating margin 14.36% 22.19%
EBITD margin - 24.65%
Return on average assets 4.22% 7.09%
Return on average equity 5.19% 8.50%
Employees 7,280 -
CDP Score - -

Address

3-2-10, Dosho-machi, Chuo-ku
OSAKA-SHI, OSK 541-8505
Japan
+81-6-62055085 (Phone)
+81-6-62055262 (Fax)

Website links

Description

Mitsubishi Tanabe Pharma Corporation is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in two business segments. The Medical Supplies segment is engaged in the research, development, manufacture and sale of ethical pharmaceutical and non-prescription drugs. The Others segment is engaged in the manufacture, purchase and sale of chemical products, as well as the management of real estate. As of March 31, 2014, the Company had 33 subsidiaries and five associated companies.

Officers and directors

Michihiro Tsuchiya Chairman of the Board
Age: 69
Masayuki Mitsuka Executive President, President, Representative Director
Age: 62
Eizo Tabaru Managing Executive Officer, Director of Accounting & Finance, Director
Age: 58
Hiromi Okatake Chief Compliance Officer, Executive Officer, Director of Legal Affairs & Intellectual Property
Takashi Kobayashi Senior Managing Executive Officer, Chief Director of CMC, Representative Director
Age: 61
Yoshiaki Ishizaki Managing Executive Officer, Chief Director of Sales, Director
Age: 62
Seiichi Murakami Managing Executive Officer, Chief Director of Drug Fostering & Evolution, Director
Age: 60
Takashi Tanaka Managing Executive Officer, Chief Director of Pharmaceutical
Kuniyoshi Wada Managing Executive Officer
Shigeru Doseki Executive Officer, Deputy Chief Director of Sales, Manager of Tokyo Office